In 2017, DeNovix launched the DS-C Spectrometer, an innovative product. This advanced spectrophotometer was designed to enhance the efficiency and accuracy of scientific research with integrated applications for UV-Vis measurements, protein quantification, and kinetic investigations. The DS-C Spectrometer is particularly valuable in the biotechnology and pharmaceutical industries, where precise and trustworthy analysis is a must.
The application of the DS-C Spectrometer in UV-Vis spectrophotometry measures the light absorption by samples in both visible and ultraviolet spectrums. This is very important in drug research, biochemical analysis, and vaccine development to determine the concentration of chemicals in a solution.
One more feature of DS-C Spectrometer that makes protein quantification easier in determining the levels of proteins in biological materials is accessible. The function of measuring proteins in material samples using specific wavelengths is expected to be quick and precise so that the presence of proteins could influence drug research and vaccine production, since incorrect analysis of protein content could possibly affect the preparation of drugs.
The DS-C Spectrometer also experiences a further increase in its utility with the kinetic study. Its ability to analyze chemical reactions and enzymatic processes in real time and in situ makes drug interaction dynamics, enzyme activity, and other involved biological processes easier to monitor for pharmaceutical industry research.
In brief, it is factual that DeNovix DS-C Spectrometer brought scientific analysis to a novel level of precision and efficiency in developing new drugs and vaccines. The DS-C Spectrometer is an essential tool in modern research, bringing forward innovation in the field of biotechnology and pharmaceutical through specialized, integrated functionalities for measurements of UV-Vis, kinetic studies, and protein quantification.
According to Coherent Market Insights spectrophotometers industry, was valued at USD 14.7 billion in 2024, with an expected growth to USD 20.4 billion by 2031. It will be reflecting a compound annual growth rate (CAGR) of 4.2% from 2024 to 2031
Rising investments in R&D, particularly in the pharmaceutical and biotechnology sectors, are propelling the demand for advanced spectrophotometric instruments. Spectrophotometers are essential instruments in scientific research and development, utilized for measuring the intensity of light absorbed or transmitted by samples. Their applications span analytical chemistry, biomedical research, environmental science, and materials science.
Increase in detection procedures of unknown chemical compounds, surge in drug discovery & drug development activities, rise in the analysis of food products, surge in demand for spectrophotometers in laboratories, and growth in the number of clinical diagnostic procedures drive the spectrophotometer market.
Furthermore, increase in adoption of accurate & technologically advanced spectrophotometers, surge in process of drug discovery & drug development, rise in the need for spectrophotometer devices in toxicology & proteomics departments, growth in R&D activities to improve spectrophotometer quality & the launch of newly advanced spectrophotometer with improved accuracy, and development & innovations in pharmaceutical & biotechnological sectors boost the growth of the spectrophotometers market.
